pentobarbital has been researched along with Weight Loss in 2 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
Weight Loss: Decrease in existing BODY WEIGHT.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yutrzenka, GJ | 1 |
Stone, T | 1 |
Anderson, S | 1 |
Tanaka, Y | 1 |
Eda, H | 1 |
Tanaka, T | 1 |
Udagawa, T | 1 |
Ishikawa, T | 1 |
Horii, I | 1 |
Ishitsuka, H | 1 |
Kataoka, T | 1 |
Taguchi, T | 1 |
2 other studies available for pentobarbital and Weight Loss
Article | Year |
---|---|
Ro 15-4513 alteration of pentobarbital dependence.
Topics: Animals; Azides; Benzodiazepines; Dose-Response Relationship, Drug; Drug Interactions; Male; Pentoba | 1996 |
Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice.
Topics: Adenocarcinoma; Adipose Tissue; Animals; Body Weight; Cachexia; Catalase; Cell Line; Colonic Neoplas | 1990 |